Sector: MedicalBioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX)
Ranking History
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 205 |
Technical : | 4 |
Performance : | 92 |
Overall: | 58 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 171 |
Technical : | 7 |
Performance : | 189 |
Overall: | 101 |
Number of Stocks: | 306 |
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 194 |
Technical : | 90 |
Performance : | 182 |
Overall: | 174 |
Number of Stocks: | 306 |
Headlines
- BioCryst Announces Pricing of Public Offering of Common Stock
Nov 19, 2009 08:45 PM | BCRX, MS
- BioCryst Announces Proposed Public Offering of Common Stock
Nov 17, 2009 06:30 AM | BCRX, MS
- Dr. Stockpick Announces Daily Stock Watch
Nov 05, 2009 01:55 PM | BCRX, GNVC
- BioCryst Receives First Peramivir Order From U.S. Government
Nov 05, 2009 07:03 AM | BCRX
- Indices Barely Salvage Gains In Volatile FOMC Announcement Session
Nov 04, 2009 08:43 PM | AIG, BCRX, CGA, GS, HGSI, QXM
- Shionogi applies for new flu drug with eye to start sales next fall
Nov 04, 2009 07:03 AM | BCRX
- BioCryst's Partner Shionogi Files for Peramivir Regulatory Approval in Japan
Nov 04, 2009 07:02 AM | BCRX
- Choppy Session Ends Positive
Nov 02, 2009 08:53 PM | AIG, AKAM, AMSC, BCRX, HGSI, NTRI
- BioCryst to Present at Oppenheimer Healthcare Conference
Oct 29, 2009 06:00 PM | BCRX
- BioCryst Reports Third Quarter 2009 Financial Results and Provides Corporate Update
Oct 29, 2009 07:01 AM | BCRX
- BioCryst Pharmaceuticals announces pricing of public offering
Nov 20, 2009 09:58 AM | BCRX
- KBR, RadioShack, WebMD Health are big movers
Oct 26, 2009 05:51 PM | ALD, ARCC, BCRX, HLTH, IO, KBR
- Intravenous flu drug given emergency OK
Oct 24, 2009 10:41 AM | BCRX
- YRC Worldwide, AIG, Blockbuster are big movers
May 15, 2009 06:10 PM | AIG, ANF, BBI, BCRX, CHE, HIG
- Stock in Focus: Sunwin International Neutraceuticals -- September 16, 2009
Sep 16, 2009 09:51 AM | BCRX, MRK, PFE, SUWN
- Market Pulse Breaking News Alert for Tuesday, August 25, 2009: MNGA -- MagneGas Appoints Internal Manufacturer's Rep to Further Promote Fuel Sales in the $680 MM Metal Working Market!
Aug 25, 2009 09:54 AM | BCRX, FNM
- Stock on the Move: China Armco Metals -- August 25, 2009
Aug 25, 2009 09:52 AM | BCRX, SUWN, VZ, YHOO
- BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update
Jul 30, 2009 07:53 AM | BCRX
- BioCryst Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 30, 2009
Jul 28, 2009 07:02 AM | BCRX
- BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
Jul 17, 2009 07:01 AM | BCRX
- Novavax Appoints Stanley Erck to Board of Directors
Jun 26, 2009 10:03 AM | BAX, BCRX, NVAX
- BioCryst Pharmaceuticals Announces Presentation of Forodesine Data at the 45th Annual Meeting of the American Society of Clinical Oncology
May 14, 2009 06:00 PM | BCRX
- BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
May 08, 2009 07:31 AM | BCRX
- BioCryst Pharmaceuticals to Announce Peramivir Update and First Quarter 2009 Financial Results on May 8, 2009
May 07, 2009 05:00 PM | BCRX
- Form 4 Sheridan William P For: Nov 02 (10K)
Nov 04, 2009 11:45 AM
- Form 4 Babu Yarlagadda S For: Oct 26 (10K)
Oct 28, 2009 11:56 AM
- Form 4 BIOCRYST PHARMACEUTICALS For: Oct 21 Filed by: Babu Yarlagadda S (10K)
Oct 22, 2009 03:10 PM
- Form 4 BIOCRYST PHARMACEUTICALS For: Oct 20 Filed by: Babu Yarlagadda S (10K)
Oct 21, 2009 06:21 PM
- Form 4 Sheridan William P For: Oct 14 (10K)
Oct 15, 2009 04:30 PM
- Form 4 Babu Yarlagadda S For: Sep 23 (10K)
Sep 24, 2009 05:03 PM
- Form 3/A Babu Yarlagadda S For: Dec 23 (10K)
Sep 24, 2009 04:27 PM
- Form 4 BIOCRYST PHARMACEUTICALS For: Jul 17 Filed by: Mills Mike (10K)
Jul 21, 2009 01:10 PM
- Form 4 BIOCRYST PHARMACEUTICALS For: May 28 Filed by: BAKER JULIAN (10K)
Jun 01, 2009 08:47 PM
- Form 4 BIOCRYST PHARMACEUTICALS For: May 28 Filed by: Baker Biotech Capital (GP), LLC (10K)
Jun 01, 2009 08:20 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
BCRX
|
Compare to S&P
|
| YTD |
797.81 %
|
641.62 %
|
| 4 Weeks |
30.71 %
|
30.02 %
|
| 12 Weeks |
22.39 %
|
14.85 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -21.74 %
|
|
EPS Growth in Last Year: -16.67 %
|
|
Sales Growth in Last Quarter: 120.35 %
|
|
Sales Growth in Last Quarter: 18.60 %
|
|
